<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04987788</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY-18-00328-MOD003</org_study_id>
    <secondary_id>R34AG059705</secondary_id>
    <nct_id>NCT04987788</nct_id>
  </id_info>
  <brief_title>e-Motivación: Developing and Pilot Testing an App to Improve Latinos' Screening Colonoscopy Rates</brief_title>
  <official_title>e-Motivación: Developing and Pilot Testing an App to Improve Latinos' Screening Colonoscopy Rates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Department of Health and Human Services</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Icahn School of Medicine at Mount Sinai</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Among Latinos, a fast growing and underserved population, Colorectal Cancer (CRC) is the&#xD;
      third leading cause of cancer death in men and in women. Compared to non-Latino whites,&#xD;
      Latinos are less likely to be diagnosed with localized CRC and more likely to be diagnosed&#xD;
      with advanced stage disease. Of the recommended CRC screening tests, a colonoscopy allows for&#xD;
      both the detection and removal of precancerous and cancerous polyps. Although screening&#xD;
      colonoscopies can detect and prevent CRC, more than half of Latinos have not received a&#xD;
      screening colonoscopy within the recommended time frame (one screening colonoscopy per ten&#xD;
      years).&#xD;
&#xD;
      The purpose of this study is to develop and begin to test an electronically-delivered&#xD;
      motivational interviewing progressive web application (e-MI app), called Motívate. The&#xD;
      Motívate app will be offered in both English and Spanish to patients who self-identify as&#xD;
      Latino/a/x, after they receive a referral for a screening colonoscopy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A pilot study will be conducted to begin to examine the efficacy of the Motívate app for&#xD;
      improving screening colonoscopy uptake among Latinos. Participants (N=80) will be randomly&#xD;
      assigned, stratified for language, to one of two groups: Motívate app (N=40) or general&#xD;
      health information video (N=40). The results of the pilot study will inform power&#xD;
      calculations for a future randomized clinical trial that will formally test the efficacy of&#xD;
      the app. If this program of research proves the Motívate app efficacious there is a strong&#xD;
      argument to integrate the app into standard clinical care in order to reduce the overall&#xD;
      burden of CRC in the growing and vulnerable Latino community.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2021</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Colonoscopy completion</measure>
    <time_frame>Six months after enrollment</time_frame>
    <description>Screening colonoscopy completion status in medical charts six months after participants are enrolled in the study.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Motívate group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will engage with an app on an iPad, smartphone or computer.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participant receive a link to watch a general health information video.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Motívate</intervention_name>
    <description>The Motívate app can be used in English or Spanish and involves four sequential phases. 1) The engaging phase uses videos to welcome participants. 2) Patients willing to discuss the decision to have a screening colonoscopy will answer multiple-choice questions on colorectal cancer prevention - completing the focusing phase. Optional videos will offer additional information. 3) The evoking phase consists of interactive Motivational Interviewing exercises to help participants elicit motivations to get a screening colonoscopy. 4) During the planning phase, participants will view a video that will discuss the steps needed to prepare for the colonoscopy.</description>
    <arm_group_label>Motívate group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Video link</intervention_name>
    <description>General health information video link</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Self-identified as Latino/a/x;&#xD;
&#xD;
          2. English or Spanish-speaking;&#xD;
&#xD;
          3. Received a physician referral for a screening colonoscopy;&#xD;
&#xD;
          4. Has access to a tablet, smartphone, or computer with working Internet.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Hearing or vision impaired;&#xD;
&#xD;
          2. Aim 1 or 2 participant.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah J. Miller, PsyD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah J. Miller, PsyD</last_name>
    <phone>2128247783</phone>
    <email>sarah.miller@mssm.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lina Jandorf</last_name>
    <email>Lina.Jandorf@mssm.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Sarah Miller, PsyD</last_name>
      <phone>212-824-7783</phone>
    </contact>
    <contact_backup>
      <last_name>Lina Jandorf, MA</last_name>
      <phone>(212) 659-5506</phone>
    </contact_backup>
    <investigator>
      <last_name>Sarah J. Miller</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 23, 2021</study_first_submitted>
  <study_first_submitted_qc>July 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2021</study_first_posted>
  <last_update_submitted>July 23, 2021</last_update_submitted>
  <last_update_submitted_qc>July 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Icahn School of Medicine at Mount Sinai</investigator_affiliation>
    <investigator_full_name>Sarah Miller</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Colonoscopy</keyword>
  <keyword>Early Detection of Cancer</keyword>
  <keyword>Cancer Screening Tests</keyword>
  <keyword>Motivational Interviewing</keyword>
  <keyword>Mobile Health</keyword>
  <keyword>Colorectal Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All of the individual participant data collected during the trial, after deidentification.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Immediately following publication. No end date.</ipd_time_frame>
    <ipd_access_criteria>Researchers who provide a methodologically sound proposal. Any purpose. Proposals should be directed to sarah.miller@mssm.edu. To gain access, data requestors will need to sign a data access agreement. Upon request, we will provide the de-identified dataset to qualified investigators under a Data Use Agreement that provides for: 1) a commitment to using the data only for research purposes; (2) a commitment to securing the data using appropriate computer technology; and, (3) a commitment to destroying or returning the data after analyses are completed.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

